New lobbying code to boost pharma's reputation in Denmark
This article was originally published in Scrip
Executive Summary
A new type of code of conduct on lobbying has been introduced in Denmark to help improve the pharmaceutical industry's reputation in the country. The code should keep industry in line when it negotiates with policy and decision makers.